Investors

Homology Medicines is focused on advancing our genetic medicines platform as one-time treatments and potential cures for patients with rare diseases

Homology Medicines is focused on advancing our genetic medicines platform as one-time treatments and potential cures for patients with rare diseases

SEC Filing Details

Document Details

Filing Date
Jul 8, 2022
Document Date
Jul 8, 2022
Form Description
A statement of beneficial ownership of common stock by certain persons
Filing Group
Other
Company
Homology Medicines, Inc.
Issuer
Homology Medicines, Inc.